Research suggested that EBV is the primary cause of MS. What are the clinical implications, and could this transform treatment and prevention of this neurodegenerative condition?
KIST researchers unveil groundbreaking nanocoating tech, using silver nanoparticles on silica layers, providing superior antiviral, and antibacterial effects with vibrant colors for diverse applications.